Alzheimer’s Disease
Latest News in Alzheimer’s Disease
April 11, 2025
Challenges in Treating Genetically Predisposed Alzheimer Disease: Insights from APOLLOE4
Emer MacSweeney, MD, a consultant neuroradiologist and trial investigator of the phase 3 APOLLOE4 study, provided a clinical view of the latest study findings, and the difficulties with finding treatments for APOEε4/4 carriers of Alzheimer disease.
April 11, 2025
In one of the longest trials of brain stimulation in Alzheimer disease, repetitive transcranial magnetic stimulation led to a reduced decline in CDR-SB, as well as positive impacts on cognitive function and functional abilities.
831 Active Alzheimer’s Disease Clinical Trials
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS
WHAT IS
CONGRESS DOING?
© Copyright 2020-2025 Seeking Cure, Inc. All Rights Reserved. Third Party materials included herein protected under copyright law.
Seeking Cure is a registered trademark of Seeking Cure, Inc.
Use of this website and any information contained herein is governed by Seeking Cure’s Terms of Service and Privacy Policy. This website is provided for general information purposes only. This website does not provide medical advice. Always consult an appropriately licensed medical provider for diagnosis and treatment. Seeking Cure does not warrant the accuracy, completeness, or timeliness of the information. Content and other features are subject to change or termination without notice at the discretion of Seeking Cure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.